The effectiveness of Echinacea extract or composite glucosamine, chondroitin and methyl sulfonyl methane supplements on acute and chronic rheumatoid arthritis rat model - PubMed (original) (raw)

. 2013 Mar;29(2):187-201.

doi: 10.1177/0748233711428643. Epub 2011 Dec 15.

Affiliations

• PMID: 22173958
• DOI: 10.1177/0748233711428643

The effectiveness of Echinacea extract or composite glucosamine, chondroitin and methyl sulfonyl methane supplements on acute and chronic rheumatoid arthritis rat model

Nadia Ms Arafa et al. Toxicol Ind Health. 2013 Mar.

Abstract

The study aimed to investigate the effect of the oral administration for 15 days of either Echinacea (E) or genuphil (a composite of chondroitin sulphate, glucosamine and methyl sulfonyl methane [GCM]) nutraceutical supplements on female rat model of acute or chronic arthritis induced by bacterial outer membrane protein (OMP) from faecal flora of healthy and rheumatic humans. Anti-cyclic citrullinated peptide (anti-CCP2), C-reactive protein (CRP) and rheumatoid factor (RF) values increased (p < 0.05) in both arthritic groups as compared to normal values. The rheumatic markers anti-CCP2, CRP and RF values decreased significantly in E- and GCM-treated groups compared to arthritic none-treated acute or chronic groups. The results of RF values of GCM-treated groups in acute and chronic models decreased exhibiting no statistical difference compared with the normal value. Histological examinations of the hind paw sections revealed moderate inflammation, oedema and mild proliferation of synovial cells in acute arthritic rats and more damage to cartilage and bone with severe inflammation in chronic ones. Echinacea acute treated group showed edema with proliferated synovial membrane and partial damage in cartilage and bone. While in the E-chronic treated group, rough edge with destructed cartilage and bone existed. However, the acute GCM group revealed mild cartilage damage. But the chronic GCM group showed mild synovial cells proliferation and revealed no inflammation with mild cartilage damage edge. Results demonstrated the OMP arthropathic property and through promising light on arthritis treatment using E- or GCM, with the advantage of GMC results over that of E-. The composite GCM is needed for further studies over the dose and duration to assess its preventive effects against the bacterial OMP arthrogenicity.

PubMed Disclaimer

Similar articles

• The effects of three-month oral supplementation with a nutraceutical and exercise on the locomotor pattern of aged horses.
  Higler MH, Brommer H, L'Ami JJ, de Grauw JC, Nielen M, van Weeren PR, Laverty S, Barneveld A, Back W. Higler MH, et al. Equine Vet J. 2014 Sep;46(5):611-7. doi: 10.1111/evj.12182. Epub 2013 Dec 10. Equine Vet J. 2014. PMID: 24011144 Clinical Trial.
• Chondroprotective effects of a new glucosamine combination in rats: Gene expression, biochemical and histopathological evaluation.
  Ucuncu Y, Celik N, Ozturk C, Turkoglu M, Cetin N, Kockara N, Sener E, Dundar C, Arslan A, Dogan H, Kurt N, Suleyman H. Ucuncu Y, et al. Life Sci. 2015 Jun 1;130:31-7. doi: 10.1016/j.lfs.2015.03.012. Epub 2015 Mar 26. Life Sci. 2015. PMID: 25818190
• Safety evaluation and therapeutic efficacy of Habb-e-Asgand, a commonly used antirheumatic polyherbal Unani formulation.
  Subramaneyaan M, Yasmeen S, Arora VK, Tripathi AK, Banerjee BD, Ahmed RS. Subramaneyaan M, et al. Altern Ther Health Med. 2013 Sep-Oct;19(5):52-9. Altern Ther Health Med. 2013. PMID: 23981406
• Pathogenic antibody recognition of cartilage.
  Nandakumar KS. Nandakumar KS. Cell Tissue Res. 2010 Jan;339(1):213-20. doi: 10.1007/s00441-009-0816-8. Epub 2009 Jun 9. Cell Tissue Res. 2010. PMID: 19506910 Review.
• [Glucosamine and chondroitin sulfate in the treatment of arthritis].
  Angermann P. Angermann P. Ugeskr Laeger. 2003 Jan 27;165(5):451-4. Ugeskr Laeger. 2003. PMID: 12599841 Review. Danish.

Cited by

• Rheumatoid arthritis in Saudi Arabia.
  Almoallim HM, Alharbi LA. Almoallim HM, et al. Saudi Med J. 2014 Dec;35(12):1442-54. Saudi Med J. 2014. PMID: 25491208 Free PMC article. Review.
• Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement.
  Butawan M, Benjamin RL, Bloomer RJ. Butawan M, et al. Nutrients. 2017 Mar 16;9(3):290. doi: 10.3390/nu9030290. Nutrients. 2017. PMID: 28300758 Free PMC article. Review.
• Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.
  Kantor ED, Zhang X, Wu K, Signorello LB, Chan AT, Fuchs CS, Giovannucci EL. Kantor ED, et al. Int J Cancer. 2016 Nov 1;139(9):1949-57. doi: 10.1002/ijc.30250. Epub 2016 Jul 18. Int J Cancer. 2016. PMID: 27357024 Free PMC article.
• Glucosamine and Chondroitin Supplements and Risk of Colorectal Adenoma and Serrated Polyp.
  Lee DH, Cao C, Zong X, Zhang X, O'Connell K, Song M, Wu K, Du M, Cao Y, Giovannucci EL, Kantor ED. Lee DH, et al. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2693-2701. doi: 10.1158/1055-9965.EPI-20-0805. Epub 2020 Oct 14. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 33055203 Free PMC article.
• Glucosamine Use and Risk of Colorectal Cancer: Results from UK Biobank.
  Kantor ED, O'Connell K, Liang PS, Navarro SL, Giovannucci EL, Du M. Kantor ED, et al. Cancer Epidemiol Biomarkers Prev. 2022 Mar 1;31(3):647-653. doi: 10.1158/1055-9965.EPI-21-1171. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35027430 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal